Loading...
Review of the Safety and Feasibility of Rapid Infusion of Rituximab
Added to standard chemotherapy, rituximab improved survival in patients with non-Hodgkin's lymphoma; added to fludarabine-based regimens, it improved response and survival in patients with chronic B-cell lymphocytic leukemia.
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2835489/ https://ncbi.nlm.nih.gov/pubmed/20592783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.200001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|